Mycenax Biotech Inc (4726):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Mycenax Biotech Inc (4726) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8079
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mycenax Biotech Inc (Mycenax) is a biopharmaceutical company that develops and manufactures pharmaceutical formulations. The company provides pipeline portfolio encompasses investigational candidates targeted at the treatment of plaque psoriasis, glioblastoma, asthma, adult crohn’s Disease, and breast cancer and indications for treatment of patients undergoing chemotherapy. It provides services such as biopharmaceutical drug development, contract manufacturing, consultation, aseptic fill and finish, CTD support services and cell bank establishment, among others. Mycenax offers services such as upstream fermentation, downstream fermentation, sterile preparations production, regulatory and project management services. The company provides consultation services such as evaluation market and technical, project planning, project management, regulatory compliance and clinical project management, among others. Mycenax is headquartered in Zhunan, Taiwan.

Mycenax Biotech Inc (4726) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Mycenax Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mycenax Biotech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mycenax Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mycenax Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Mycenax Biotech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Mycenax Biotech Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Mycenax Biotech Enters into Co-Development Agreement with BiosanaPharma 10
Licensing Agreements 11
Mycenax Biotech Enters into Licensing Agreement For MBI-002 11
Orient Europharma Enters into Licensing Agreement with Mycenax Biotech for TuNEX 12
Equity Offering 13
Mycenax Biotech to Raise Funds through Private Placement of Shares 13
Mycenax Biotech Inc – Key Competitors 14
Mycenax Biotech Inc – Key Employees 15
Mycenax Biotech Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Mycenax Biotech Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Mycenax Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mycenax Biotech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mycenax Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mycenax Biotech Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Mycenax Biotech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Mycenax Biotech Enters into Co-Development Agreement with BiosanaPharma 10
Mycenax Biotech Enters into Licensing Agreement For MBI-002 11
Orient Europharma Enters into Licensing Agreement with Mycenax Biotech for TuNEX 12
Mycenax Biotech to Raise Funds through Private Placement of Shares 13
Mycenax Biotech Inc, Key Competitors 14
Mycenax Biotech Inc, Key Employees 15
Mycenax Biotech Inc, Other Locations 16

List of Figures
Mycenax Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Mycenax Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Mycenax Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Mycenax Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Mycenax Biotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mycenax Biotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Mycenax Biotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mycenax Biotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Mycenax Biotech Inc (4726):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Wartsila Corp (WRT1V):企業の財務・戦略的SWOT分析
    Wartsila Corp (WRT1V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Actua Corporation:企業のM&A・事業提携・投資動向
    Actua Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Actua Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • New Silkroad Culturaltainment Limited.:戦略・SWOT・企業財務分析
    New Silkroad Culturaltainment Limited. - Strategy, SWOT and Corporate Finance Report Summary New Silkroad Culturaltainment Limited. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Opsona Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Opsona Therapeutics Ltd (Opsona) is a biopharmaceutical company that conducts research, develops and commercializes new treatment for the autoimmune and inflammatory diseases and cancers. The company's OPN-305 is a humanized antibody used to reduce pro-inflammatory cytokine production that i …
  • Novelion Therapeutics Inc (NVLN):企業の財務・戦略的SWOT分析
    Novelion Therapeutics Inc (NVLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Berg LLC:医療機器:M&Aディール及び事業提携情報
    Summary Berg LLC (Berg) is a biopharmaceutical company that focus on therapeutic discovery using AI-based Interrogative biology platform. The company’s proprietary platform Interrogative Biology, combines patient biology and artificial intelligence-based analytics to understand predictive patterns o …
  • Deutsche Post AG:企業のM&A・事業提携・投資動向
    Deutsche Post AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Deutsche Post AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Ontario Power Generation Inc:電力:M&Aディール及び事業提携情報
    Summary Ontario Power Generation Inc (OPG) is an electric utility. It generates and sells energy. The company produces power from nuclear, hydro, and thermal sources. OPG has long-term lease arrangement and related agreements with Bruce Power related to the Bruce nuclear generating stations. It also …
  • Hitachi Kokusai Electronic Inc.:企業の戦略・SWOT・財務情報
    Hitachi Kokusai Electronic Inc. - Strategy, SWOT and Corporate Finance Report Summary Hitachi Kokusai Electronic Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Costcutter Supermarkets Group Ltd:企業の戦略・SWOT・財務分析
    Costcutter Supermarkets Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Costcutter Supermarkets Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Bank Pekao SA:戦略・SWOT・企業財務分析
    Bank Pekao SA - Strategy, SWOT and Corporate Finance Report Summary Bank Pekao SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Voya Financial Inc:企業の戦略・SWOT・財務分析
    Voya Financial Inc - Strategy, SWOT and Corporate Finance Report Summary Voya Financial Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • GenePOC Inc-医療機器分野:企業M&A・提携分析
    Summary GenePOC Inc (GenePOC), a subsidiary of Debiopharm Group is a medical device company that develops rapid molecular devices for providing targeted therapy. The company offers on-the-spot diagnostic devices for achieving optimal patient management. It offers diagnostic instruments based on a no …
  • Gulf Pharmaceutical Industries PSC (JULPHAR):製薬・医療:M&Aディール及び事業提携情報
    Summary Gulf Pharmaceutical Industries PSC (Julphar) is a pharmaceutical company that manufactures and distributes medicines in the Middle East and North Africa (MENA) region. The company's product portfolio consists of antibiotics, antiseptics, wound care and biotechnology, women care, adult primar …
  • Interpace Biosciences Inc (IDXG):企業の製品パイプライン分析
    Summary Interpace Biosciences Inc (Interpace Biosciences) formerly Interpace Diagnostics Group Inc, is a developer of molecular diagnostics tests. The company offers PancraGen, a DNA based molecular test that aids in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its pathf …
  • Mapfre SA (MAP):企業の財務・戦略的SWOT分析
    Mapfre SA (MAP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Next Plc:企業の戦略・SWOT・財務情報
    Next Plc - Strategy, SWOT and Corporate Finance Report Summary Next Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • SDIX LLC:医療機器:M&Aディール及び事業提携情報
    Summary SDIX LLC (SDIX), a subsidiary of OriGene Technologies Inc, is an immuno-solutions company that develops antibody-based solutions. The company provides IVD solutions and premade antibiotics, among others. Its IVD solutions provide co-development of analyte-specific reagents, diagnostic menu e …
  • Canada Pension Plan Investment Board:企業の戦略・SWOT・財務情報
    Canada Pension Plan Investment Board - Strategy, SWOT and Corporate Finance Report Summary Canada Pension Plan Investment Board - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Nila Infrastructures Ltd:企業の戦略・SWOT・財務情報
    Nila Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report Summary Nila Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆